We belong to a new breed of biotech investor that strongly believes in the concept of “smart money”. We combine our capital with our collaborative drug development team to deliver a unique investment formulation.
KreaMedica invests in fast-growing biotechnology companies that develop innovative drugs or disruptive technologies. We focus on biotech companies whose products address areas of significant unmet medical needs and thus have above-average sales and profit growth potential. Furthermore, we focus on the earlier phases of development, where most of the funding challenges exist.